SUBSCRIBE
SUBSCRIBE
News   Business

Addex Pharmaceuticals Appoints Laurent Galibert Head of Inflammation Business Unit

July 28, 2008 | 
1 min read
GENEVA, SWITZERLAND--(Marketwire - July 28, 2008) - Addex Pharmaceuticals is pleased to announce the appointment of Laurent Galibert to its executive management team, as head of the Addex Inflammation Business Unit.
People Europe
MORE ON THIS TOPIC
Group of blue paper boats following on red on yellow background, mass manipulation
Mergers & acquisitions
How Akero’s MASH Success Drove Roche’s $3.5B Takeout of 89bio
October 2, 2025
 · 
3 min read
 · 
Annalee Armstrong
Hand shake icon on wooden cube block which connection with human icon for business deal and agreement concept.
Mergers & acquisitions
Halozyme’s $900M Elektrofi Buyout Brings Two Big Pharma Partners Together
October 2, 2025
 · 
2 min read
 · 
Tristan Manalac
Success Way and freedom. Business woman walking to the exit through an open door.
Cell therapy
Takeda Exits Cell Therapy Amid Strategic Pivot, Dealing Blow to Once Promising Modality
October 2, 2025
 · 
2 min read
 · 
Tristan Manalac
Receiving dividends among investors. Art collage.
Cancer
AnaptysBio Plans Business Split To Sharpen Focus on Asset Value
October 1, 2025
 · 
2 min read
 · 
Tristan Manalac